Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Stephens Investment Management Group LLC

Stephens Investment Management Group LLC decreased its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 4.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 170,924 shares of the company's stock after selling 8,613 shares during the quarter. Stephens Investment Management Group LLC owned about 0.14% of Henry Schein worth $11,707,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Guggenheim Capital LLC raised its position in Henry Schein by 2.5% during the 4th quarter. Guggenheim Capital LLC now owns 6,428 shares of the company's stock worth $445,000 after buying an additional 159 shares during the last quarter. UMB Bank n.a. increased its position in shares of Henry Schein by 23.2% in the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after buying an additional 201 shares in the last quarter. Humankind Investments LLC lifted its holdings in Henry Schein by 7.4% during the fourth quarter. Humankind Investments LLC now owns 3,057 shares of the company's stock valued at $212,000 after purchasing an additional 211 shares in the last quarter. J. Safra Sarasin Holding AG boosted its holdings in Henry Schein by 1.1% in the 4th quarter. J. Safra Sarasin Holding AG now owns 22,098 shares of the company's stock worth $1,529,000 after buying an additional 231 shares during the last quarter. Finally, Allworth Financial LP raised its stake in Henry Schein by 24.5% in the 1st quarter. Allworth Financial LP now owns 1,178 shares of the company's stock valued at $78,000 after purchasing an additional 232 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

Henry Schein Price Performance

NASDAQ:HSIC traded down $2.74 during trading hours on Monday, hitting $70.68. The company's stock had a trading volume of 3,298,327 shares, compared to its average volume of 1,714,515. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.75 and a current ratio of 1.38. The business's 50-day moving average is $71.56 and its two-hundred day moving average is $71.33. The company has a market capitalization of $8.60 billion, a PE ratio of 22.09, a PEG ratio of 2.37 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The business had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. During the same period in the prior year, the company posted $1.10 EPS. The business's revenue for the quarter was down .1% on a year-over-year basis. As a group, research analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Piper Sandler dropped their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a report on Wednesday, April 30th. Evercore ISI upped their target price on shares of Henry Schein from $72.00 to $78.00 and gave the stock an "in-line" rating in a research note on Wednesday, July 9th. Wells Fargo & Company lowered their price objective on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Leerink Partners set a $75.00 target price on Henry Schein in a report on Monday. Finally, Robert W. Baird restated a "neutral" rating and set a $72.00 price objective (down previously from $82.00) on shares of Henry Schein in a research report on Monday. Seven equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Henry Schein presently has an average rating of "Moderate Buy" and a consensus price target of $78.36.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.